IEIL to Acquire Arysta LifeScience Corporation From Olympus Capital Holdings Asia



    TOKYO, October 21 /CNW/ - Industrial Equity Investments Limited ("IEIL"),
an international investment company located in the Republic of Ireland, today
announced it has signed a definitive agreement to acquire Arysta LifeScience
Corporation, from funds advised by Olympus Capital Holdings Asia and its
co-investors. The acquisition is IEIL's first investment in Japan since it was
established in 2005. The Permira Funds own the Irish company. The enterprise
value is approximately JPY 250bn (US$2.2bn). Completion of the transaction,
which is subject to regulatory review and approvals, is anticipated to occur
in first quarter 2008.

    Headquartered in Tokyo, Arysta LifeScience is the world's tenth largest
agrochemical company. The company markets a portfolio of over 150 products in
more than 125 countries with approximately 2,200 employees. Since its founding
in 2001, Arysta LifeScience has built a reputation as one of the most agile,
high-performance companies in the global agrochemical industry.

    Margaret O'Connor, chairperson of IEIL, commented, "We are delighted to
be acquiring a truly global business headquartered in Japan and look forward
to supporting the management in their growth going forward."

    Chris Richards, CEO of Arysta LifeScience, said, "Our continued success
comes from a culture that is relentlessly focused on delivering innovative
crop protection solutions that help our customers become more successful.
Based on our strong product range and global reach, our employees have driven
aggressive global growth through product development and strategic
acquisition. Olympus Capital has provided consistent support for our growth
over the last five years. We are now excited to look to the future with IEIL,
who shares our vision and ambition to further accelerate our growth plans over
the coming years."

    Olympus Capital, an independent firm that has been in the Asian private
equity business for more than 10 years, has entered into more than 10
strategic partnerships throughout the region. The firm completed an initial
investment in Arysta LifeScience in 2002, partnering with then existing owners
Tomen Corporation (now owned by Toyota Tsusho) and Nichimen Corporation (now
part of Sojitz Corporation), who subsequently sold their stakes to the Olympus
Group. During this period, Olympus Capital helped Arysta LifeScience to
acquire more than JPY50bn (US$450 million) of companies and products around
the world.

    The Permira Funds provided all the equity for the IEIL's first
acquisition in Japan. This investment demonstrates Permira's ability to
identify strong investment opportunities in the region following its recent
investment in Galaxy Entertainment Group of Hong Kong.

    Goldman Sachs, Lehman Brothers and Freshfields Bruckhaus Deringer acted
as advisers to Arysta LifeScience and the sellers. JP Morgan, Clifford Chance,
PricewaterhouseCoopers and Permira Ireland Limited acted as advisers to IEIL.

    About Arysta LifeScience Corporation

    Headquartered in Tokyo, Japan, Arysta LifeScience is the world's largest
privately held crop protection and life science company with 2006 revenues of
JPY124.1 billion (US$1 billion). An entrepreneurial provider of crop
protection and life science products in more than 125 countries worldwide,
Arysta LifeScience specializes in marketing and distribution of respected crop
protection brands and life science products in harmony with the needs of
global partners. More information on the company is available at:
www.arystalifescience.com.

    About IEIL

    Established in 2005, IEIL is a private investment company located in the
Republic of Ireland.

    About Permira

    Permira is a leading international private equity firm. The Permira Funds
make long-term investments to transform the performance of businesses, helping
management to realise new visions and build stronger and more sustainable
organizations.

    The firm's teams are based in Frankfurt, Guernsey, London, Luxembourg,
Madrid, Milan, New York, Paris, Stockholm, and Tokyo, advising funds with a
total committed capital of approximately EUR22 billion (US$30 billion). Since
1985, the Permira Funds have completed over 180 private equity transactions.

    For more information visit: www.permira.com

    About Olympus Capital Holdings Asia

    Olympus Capital Holdings Asia is a leading middle market private equity
firm specializing in partnering with Asian shareholders and management teams
to expand their businesses regionally and globally. Olympus Capital has a
network of investment and operating professionals located in offices in Tokyo,
Delhi, Hong Kong, Seoul, Shanghai and New York. Since its establishment in
1997, Olympus Capital has invested over $1.2 billion on behalf of funds and
co-investors in more than 25 portfolio companies throughout Asia. Olympus
Capital, one of the early entrants to the Japan private equity market,
completed its first Japanese investments in partnership with a major Japanese
bank and a trading company in 2000, and established its Tokyo office soon
thereafter in 2001. Target industry sectors include business services,
agribusiness, financial services and environmental services. Recent
investments include Quatrro BPO Solutions (India) and Kyoto Kimono Yuzen
(Japan).




For further information:

For further information: Arysta LifeScience Corporation Linda Frerichs,
+1-919-678-4948 Email: linda.frerichs@arystalifescience.com

Organization Profile

ARYSTA LIFESCIENCE CORPORATION

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890